By Meghan Hall The life sciences industry is continuing to propel the local office market forward. Major life sciences developer and investor BioMed Realty has notched another acquisition in Seattle, paying $220 million, or about $1,048 per square foot, for a modern, tech-centric office property. Public records indicate that the deal closed on November 15th, […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Seattle voters are on track to double the city's dedicated transit sales...
ByThe RegistryNovember 4, 2026A Seattle multifamily investor has paid about $246,000 per unit for a...
ByThe RegistryNovember 4, 2026SITE Centers has agreed to sell its retail condominium portfolio in Portland’s...
ByThe RegistryNovember 4, 2026Madison Realty Capital and Red Cove Capital have stacked $131.9 million of...
ByThe RegistryNovember 4, 2026